HOSPITAL BARCELONA SCIAS

logotipo SCIAS

The Hospital de Barcelona - SCIAS participated in the first phase IIa, multicentre studies to assess the safety and efficacy of bone regeneration of progenitor cells processed with the Aastrom Replicell bioreactor in atrophic pseudarthrosis.